Have a personal or library account? Click to login
Reverse Payment Patent Settlements in the Pharmaceutical Sector and Competition Law – Do Lundbeck and Actavis Help to Bridge the Views Across the Atlantic Regarding the Delayed Market Entry of Cheaper, Generic Medicines? Cover

Reverse Payment Patent Settlements in the Pharmaceutical Sector and Competition Law – Do Lundbeck and Actavis Help to Bridge the Views Across the Atlantic Regarding the Delayed Market Entry of Cheaper, Generic Medicines?

International and Comparative Law Review
Volume 13 (2013): Issue 1 (June 2013)
By: Pawan Dutt and  Tanel Kerikmäe  
Open Access
|Jan 2018

Authors

Pawan Dutt

pawan.dutt@ttu.ee

Lecturer at Chair of Law and Technology, Tallinn Law School, Faculty of Social Sciences, Tallinn University of Technology,, Tallinn, Estonia

Tanel Kerikmäe

kerikmae@ttu.ee

Professor and head of the Jean Monnet Chair of European Law, Tallinn Law School, Faculty of Social Sciences, Tallinn University of Technology,, Tallinn, Estonia
DOI: https://doi.org/10.1515/iclr-2016-0056 | Journal eISSN: 2464-6601 | Journal ISSN: 12138770
Journal RSS Feed
Language: English
Page range: 23 - 38
Published on: Jan 24, 2018
Published by: Palacký University Olomouc
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
competition,
intellectual property,
pharmaceutical industry,
reverse payment patent,
European Union,
Unites States
Related subjects:
Law,
International law, foreign law, comparative law,
International law, foreign law, comparative law, other,
European law,
European law, other,
Public law,
Constitutional jurisdiction, administrative procedural law

© 2018 Pawan Dutt, Tanel Kerikmäe, published by Palacký University Olomouc
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 13 (2013): Issue 1 (June 2013)Next article